The Multiple Sclerosis Therapeutics Market is projected to grow at a rate of 2% in terms of value, from USD 21.92 Billion in 2019 to reach USD 26.69 Billion by 2027. Multiple sclerosis (MS) is a demyelinating disease in which the insulating sheaths of nerve cells in the brain and spinal cord are damaged. The […]